Abstract
A preliminary report described the results of radiotherapy treatment in 90 patients with laparotomy-negative stage I and II Hodgkin's disease. 15 This group has now been followed a minimum of five years. The maximum follow-up is just over ten years. The findings in the preliminary report are now confirmed. The projected ten year survival is approximately 93%; the projected ten year disease free survival is about 60%. None of the patients received total nodal radiotherapy. More than half of the patients received no elective irradiation below the diaphragm and some of them received less than full mantle treatment. Present philosophy in the management of Hodgkin's disease is tentatively based on combining the results of the treatment of patients variously staged, either with or without laparotomy or with or without lymphangiography. Analysis of patterns of failure in patients who have had a laparotomy strongly suggest that a more conservative radiotherapy approach than is currently the norm in most institutions can be equally effective. Indications for a combined chemotherapy/ radiotherapy program for mediastinal presentations is discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
